News
Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!
Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...
The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...
Semaglutide and tirzepatide prescriptions within Epic-affiliated health care systems increased slightly between 2021 and 2024, but their uptake remained limited, with only 3% of eligible patients ...
Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...
Jaime Almandoz, MD, MBA, of UT Southwestern Medical Center, speaks on results of a study that investigated tirzepatide uptake ...
GLP-1 medications like Semaglutide, Tirzepatide, and even oral options that target key metabolic processes. TMatesis positioning itself as a go-to provider in this space, offering affordable ...
As the Food and Drug Administration cracks down on compounded versions of popular weight loss drugs Wegovy (semaglutide) and Zepbound (tirzepatide), Americans who rely on these cheaper medications ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results